Free tool
Stocks listed on Nasdaq GS
We cover 67 companies listed on Nasdaq GS. The median market value in the group is $12.70B. Across the group, the median move over the past trading day is −0.22%. 68% of the 66 with a 200-day average trade above it. Price change over the past year runs from −45.0% to +161.5% across the middle 80 percent of the group, with a median of +29.3%.
Other lists in this group
Table
67 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | $148.09 | +10.25% | +22.48% | +32.51% |
| VRTX | Vertex Pharmaceuticals Incorporated | $547.29 | +11.60% | +21.05% | +40.66% |
| ISRG | Intuitive Surgical, Inc. | $370.42 | +2.38% | −34.09% | −21.38% |
| SNY | Sanofi | $45.42 | −0.26% | −0.60% | −4.33% |
| REGN | Regeneron Pharmaceuticals, Inc. | $814.79 | +17.21% | +5.24% | +39.36% |
| ARGX | argenx SE | $1,047.10 | +20.05% | +24.66% | +47.90% |
| MRNA | Moderna, Inc. | $149.66 | +168.18% | +384.96% | +496.25% |
| NTRA | Natera, Inc. | $338.45 | +34.19% | +47.90% | +107.59% |
| MDLN | Medline Inc. | $35.64 | −12.02% | −12.26% | −13.07% |
| RVMD | Revolution Medicines, Inc. | $215.44 | +17.18% | +172.64% | +466.35% |
| IDXX | IDEXX Laboratories, Inc. | $553.44 | −2.83% | −17.40% | −13.64% |
| ONC | BeOne Medicines AG | $375.80 | +13.72% | +20.83% | +25.21% |
| RPRX | Royalty Pharma plc | $61.80 | +3.05% | +60.57% | +74.00% |
| ILMN | Illumina, Inc. | $224.84 | +16.51% | +67.35% | +125.88% |
| DXCM | DexCom, Inc. | $88.96 | +18.85% | +33.69% | +16.47% |
| GEHC | GE HealthCare Technologies Inc. | $73.31 | +14.35% | −11.40% | −1.15% |
| BIIB | Biogen Inc. | $221.07 | +7.52% | +24.32% | +62.12% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $239.00 | −17.13% | −40.28% | −47.38% |
| BNTX | BioNTech SE | $112.56 | +21.75% | +16.41% | +9.27% |
| INSM | Insmed Incorporated | $124.39 | +19.46% | −29.77% | −7.54% |
| ROIV | Roivant Sciences Ltd. | $36.75 | +8.60% | +67.58% | +206.51% |
| INCY | Incyte Corporation | $128.12 | −1.39% | +26.33% | +51.01% |
| GH | Guardant Health, Inc. | $170.92 | +19.01% | +68.00% | +169.17% |
| GMAB | Genmab A/S | $33.75 | +16.38% | +6.07% | +36.20% |
| VTRS | Viatris Inc. | $16.85 | −5.66% | +37.39% | +66.19% |
| MEDP | Medpace Holdings, Inc. | $619.05 | +8.42% | +8.41% | +30.74% |
| JAZZ | Jazz Pharmaceuticals plc | $249.29 | −2.97% | +43.97% | +100.35% |
| ASND | Ascendis Pharma A/S | $250.25 | −1.65% | +17.33% | +29.66% |
| NBIX | Neurocrine Biosciences, Inc. | $156.59 | −14.35% | +11.37% | +13.36% |
| BBIO | BridgeBio Pharma, Inc. | $79.37 | −7.22% | +1.45% | +60.05% |
| COO | The Cooper Companies, Inc. | $72.68 | +0.86% | −10.39% | −1.93% |
| EXEL | Exelixis, Inc. | $56.10 | −0.73% | +28.73% | +45.68% |
| ICLR | ICON Public Limited Company | $168.93 | −6.27% | −10.46% | −2.91% |
| BMRN | BioMarin Pharmaceutical Inc. | $65.61 | +5.70% | +10.36% | +11.85% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $89.12 | +3.89% | +31.46% | +308.99% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $538.88 | +0.01% | −9.26% | +26.78% |
| HALO | Halozyme Therapeutics, Inc. | $107.06 | +28.29% | +52.27% | +46.30% |
| TEM | Tempus AI, Inc. | $68.48 | +59.63% | +9.81% | −6.49% |
| TECH | Bio-Techne Corporation | $72.38 | +0.43% | +21.73% | +29.33% |
| BTSG | BrightSpring Health Services, Inc. | $61.35 | −15.33% | +59.77% | +156.37% |
| ALGN | Align Technology, Inc. | $159.14 | −9.37% | +1.99% | +12.09% |
| CYTK | Cytokinetics, Incorporated | $79.20 | −0.31% | +28.30% | +109.36% |
| KRYS | Krystal Biotech, Inc. | $359.76 | −1.23% | +45.70% | +143.67% |
| IONS | Ionis Pharmaceuticals, Inc. | $63.36 | +14.58% | −20.47% | +48.21% |
| PRAX | Praxis Precision Medicines, Inc. | $377.37 | +27.57% | +31.76% | +704.28% |
| ENSG | The Ensign Group, Inc. | $180.63 | −1.37% | +3.89% | +5.01% |
| HSIC | Henry Schein, Inc. | $90.38 | +5.45% | +17.65% | +31.02% |
| RGEN | Repligen Corporation | $180.30 | +24.05% | +9.70% | +51.67% |
| ATRA | Atara Biotherapeutics, Inc. | $9.38 | +20.10% | −47.21% | −24.05% |
| CVRX | CVRx, Inc. | $3.27 | −33.94% | −53.94% | −56.75% |
| GOSS | Gossamer Bio, Inc. | $0.17 | −15.17% | −93.96% | −92.93% |
| DH | Definitive Healthcare Corp. | $0.79 | +11.75% | −66.73% | −80.44% |
| OM | Outset Medical, Inc. | $4.25 | −9.96% | +14.86% | −69.56% |
| PLRX | Pliant Therapeutics, Inc. | $1.16 | +8.41% | −7.20% | −31.36% |
| SPRO | Spero Therapeutics, Inc. | $1.22 | +2.09% | −48.09% | −38.38% |
| XBIT | XBiotech Inc. | $2.31 | +1.76% | −2.94% | −33.62% |
| PMVP | PMV Pharmaceuticals, Inc. | $1.31 | +19.09% | +6.50% | −7.75% |
| BOLD | Boundless Bio, Inc. | $2.92 | +18.02% | +138.93% | +155.70% |
| MCRB | Seres Therapeutics, Inc. | $4.76 | −0.83% | −68.58% | −74.79% |
| MGX | Metagenomi Therapeutics, Inc. | $1.22 | +0.83% | −26.95% | −34.41% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $1.96 | −72.36% | −72.74% | −74.90% |
| PETS | PetMed Express, Inc. | $1.79 | −10.95% | −45.76% | −43.35% |
| KYNB | Kyntra Bio, Inc. | $8.11 | +16.20% | −11.52% | −22.66% |
| QNCX | Quince Therapeutics, Inc. | $31.31 | +61.64% | +4.37% | +100.71% |
| NXTC | NextCure, Inc. | $5.83 | +7.56% | −56.10% | +11.37% |
| TXMD | TherapeuticsMD, Inc. | $2.28 | +10.68% | +38.18% | +103.57% |
| TRIB | Trinity Biotech plc | $9.59 | −22.97% | +1178.67% | +547.97% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.